- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lu-177-DOTA-Octreotide
Total 165 results
-
OHSU Knight Cancer InstituteNovartis; Oregon Health and Science UniversityNot yet recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMetastatic Adrenal Gland Pheochromocytoma | Stage III Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 | Locally Advanced Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Metastatic Parathyroid Gland Carcinoma and other conditionsUnited States
-
Tine Gregersen, MDRecruitingNeuroendocrine NeoplasmDenmark
-
National Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
Lawson Health Research InstituteActive, not recruiting
-
Advanced Accelerator ApplicationsCompletedCarcinoid Tumor of the Small Bowel | Neuroendocrine TumourUnited States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Digestive System Neuroendocrine Neoplasm | Metastatic Neuroendocrine TumorUnited States
-
Sinotau Pharmaceutical GroupRecruiting
-
National Cancer Institute (NCI)Recruiting
-
National Cancer Centre, SingaporeNovartis; Advanced Accelerator ApplicationsRecruitingMetastatic Nasopharyngeal CancerSingapore
-
AHS Cancer Control AlbertaRecruitingCarcinoma, NeuroendocrineCanada
-
University Health Network, TorontoCancer Care Ontario; Ozmosis Research Inc.; Canadian Molecular Imaging Probe...Active, not recruitingNeuroendocrine TumorsCanada
-
AHS Cancer Control AlbertaCross Cancer InstituteActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruiting
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingGrade 1 Meningioma | Grade 2 Meningioma | Grade 3 Meningioma | Recurrent Meningioma | Unresectable MeningiomaUnited States
-
Stanford UniversityNovartis PharmaceuticalsRecruitingGastroenteropancreatic Neuroendocrine TumorUnited States
-
CHU de Quebec-Universite LavalRecruitingNeuroendocrine Tumors | Carcinoma, Neuroendocrine | Carcinoid TumorCanada
-
Radboud University Medical CenterCompletedMetastatic Clear Cell Renal Cell CarcinomaNetherlands
-
Advanced Accelerator ApplicationsApproved for marketingNeuroendocrine TumorsUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Pancreatic Neuroendocrine Tumor | Pancreatic Neoplasm | Stage III Pancreatic Neuroendocrine Tumor AJCC v8 | Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 | Unresectable Pancreatic Neuroendocrine TumorUnited States, Canada
-
Sue O'DorisioAdvanced Accelerator ApplicationsWithdrawnNeuroendocrine Tumors | Pheochromocytoma | ParagangliomaUnited States
-
National Cancer Institute (NCI)RecruitingLocally Advanced Lung Neuroendocrine Neoplasm | Lung Neuroendocrine Neoplasm | Metastatic Lung Neuroendocrine Neoplasm | Recurrent Lung Neuroendocrine Neoplasm | Unresectable Lung Neuroendocrine Neoplasm | Advanced Lung Neuroendocrine Tumor | Functioning Lung Neuroendocrine Tumor | Lung Neuroendocrine... and other conditionsUnited States
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Unknown
-
Instituto Nacional de Cancer, BrazilUnknown
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Gastroenteropancreatic Neuroendocrine TumorChina
-
Peking UniversityNot yet recruiting
-
Bivision Pharmaceuticals, Inc.Recruiting
-
Nanjing First Hospital, Nanjing Medical UniversityUnknownMetastatic Castration-resistant Prostate CancerChina
-
Lund University HospitalCompletedNeuroendocrine Tumors | Liver MetastasesSweden
-
POINT BiopharmaActive, not recruitingSoft Tissue Sarcoma | Colorectal Cancer | Esophageal Cancer | Cholangiocarcinoma | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Melanoma (Skin)United States, Canada
-
Jonsson Comprehensive Cancer CenterPOINT BiopharmaActive, not recruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate AdenocarcinomaUnited States
-
ITM Solucin GmbHNot yet recruitingLymphoma | CNS Tumor | Solid Tumor, Childhood | Somatostatin Receptor Positive | NET
-
Lantheus Medical ImagingPOINT BiopharmaAvailableCastration-Resistant Prostatic CancerUnited States
-
Cellbion Co., Ltd.Recruiting
-
Ludwig Institute for Cancer ResearchRadboud University Medical CenterCompletedMetastatic Renal Cell CarcinomaNetherlands
-
Novartis PharmaceuticalsRecruitingGlioblastomaSpain, Switzerland, France, Portugal, United States
-
Ralph NULL SalloumChildren's Hospital Medical Center, CincinnatiRecruitingHigh Grade Glioma | Medulloblastoma | Meningioma | Anaplastic Ependymoma | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Refractory Malignant Glioma | Refractory Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary... and other conditionsUnited States
-
Advanced Accelerator ApplicationsActive, not recruitingNeuroendocrine TumorsUnited Kingdom, Portugal, Spain, France, United States
-
University of IowaNovartisRecruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
University College, LondonNot yet recruitingMedullary Thyroid Carcinoma | Bronchial and Thymic Neuroendocrine Tumour | Paraganglioma/ Phaeochromocytoma | Those Requiring Repeat Peptide Receptor Radionuclide Therapy
-
Marnix LamCompletedNeuroendocrine Tumors | Liver MetastasesNetherlands
-
Molecular Targeting Technologies, Inc.ClinSmartRecruitingNeuroendocrine TumorsUnited States
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
Peking Union Medical College HospitalRecruitingNeuroendocrine TumorsChina
-
University of California, DavisNational Institutes of Health (NIH)RecruitingMetastatic CancerUnited States
-
Providence Health & ServicesExelixis; Advanced Accelerator Applications SAActive, not recruitingNeuroendocrine TumorsUnited States
-
Jules Bordet InstituteCompletedGastroenteropancreatic Neuroendocrine TumorsBelgium
-
University of California, DavisUnited States Department of DefenseRecruitingMetastatic Nonsmall Cell Lung CancerUnited States
-
University of California, DavisRecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States